Empowering the Voice of Kansas Pharmacy

Log in

NASPA Pharmacy-Based Point-of-Care Test & Treat Certificate Program

  • 08/06/2022
  • 08/20/2022
  • 2 sessions
  • 08/06/2022, 8:30 AM 12:30 PM (CDT)
  • 08/20/2022, 2:00 PM 6:00 PM (CDT)
  • Topeka, Webinar, Wichita

Registration


Registration is closed


LIVE PROGRAMMING

NASPA Pharmacy-Based Point-of-Care Test & Treat National Certificate Program - Live Component

Point-of-care testing empowers clinicians to use effective, fast technology to aid their decision making at the “point-of-care” to improve patient health. This course provides an opportunity to gain the skills and information necessary to develop a testing program such as influenza, Group A Streptococcus, HIV, Hepatitis C, coronaviruses, and chronic diseases. Pharmacists and pharmacies are increasingly offering this public health service to promote prevention, early detection, and disease management.


The 20- hour ACPE-accredited certificate program includes comprehensive material regarding key disease states, physical assessment, point-of-care tests and treatment, and business models. Comprised of 16 hours of home study and 4 hours of live training, including a skills assessment, this course will put you on the road to a test and treat program in your pharmacy. Review the full course agenda here.

WHEN/WHERE

Option 1: Virtual
8:30 a.m. to 12:30 p.m. | Saturday, Aug. 6, 2022
Zoom log-in details will be provided to registrants prior to the class. Participants are required to have active video and audio feed through your computer or mobile device. 

Option 2: Wichita - in person
2 p.m. to 6 p.m. | Saturday, Aug. 20, 2022

Training will take place at Rainbows United, 3223 N Oliver, Wichita, KS 67220

COST

KPhA Member Pharmacist | $325
KPhA Member New Practitioner | $250
KPhA Member Technician/Student | $200
Non-Member Technician/Student | $250
Non-Member Pharmacist | $450

Once you access the home study portion, refunds for the class are no longer available.

OBJECTIVES
for Pharmacists

  1. Identify opportunities for expanding patient-centered services in pharmacy settings, using point-of-care testing and treatment.
  2. Discuss the value and limitations of patient reported symptoms, medical history, and drug allergies.
  3. Describe and perform the following physical assessments, when appropriate to patient care: Blood Pressure, Pulse, Respiratory Rate, Oxygenation, and Cervical Lymph Node Inspection
  4. Describe and perform the following specimen collections used in point of care testing: Throat swab, and Nasal swab
  5. Identify characteristics of exemplar infectious diseases (e.g. influenza, Group A Streptococcus, Human Immunodeficiency Virus, Hepatitis C, Coronaviruses) regarding: Causative agents, Transmission, Immunizations, Symptoms and Presentation, Appropriate treatment, Point-of-Care testing
  6. Define and contrast the following terms as they relate to point-of-care testing in pharmacies: CLIA, CLIA-waived, Collaborative Agreement, Protocol, Prescribe, Diagnose
  7. Explain the value and limitations of Point-of-Care Tests, including rapid diagnostic tests, and list the steps a pharmacist can take to improve test performance.
  8. Apply all information to patient-specific cases based on common pharmacy-based patient interaction.

for Technicians

  1. Identify opportunities for expanding patient-centered services in pharmacy settings, using point-of-care testing and treatment.
  2. Discuss the value and limitations of patient reported symptoms, medical history, and drug allergies.
  3. Describe and perform under the supervision of a pharmacist the following physical assessments, when appropriate to patient care: Blood Pressure, Pulse, Respiratory Rate, Oxygenation, and Cervical Lymph Node Inspection
  4. Describe and perform the following specimen collections used in point of care testing: Throat swab, and Nasal swab
  5. Identify characteristics of exemplar infectious diseases (e.g. influenza, Group A Streptococcus, Human Immunodeficiency Virus, Hepatitis C, Coronaviruses) regarding: Causative agents, Transmission, Immunizations, Symptoms and Presentation, and Point-of-Care testing
  6. Define and contrast the following terms as they relate to point-of-care testing in pharmacies: CLIA, CLIA-waived, Collaborative Agreement, Protocol, Prescribe, Diagnose
  7. Explain the value and limitations of Point-of-Care Tests, including rapid diagnostic tests.

PRESENTED BY
Amanda Applegate, PharmD, BCACP,   is the director of practice development for the Kansas Pharmacists Association. She has 10 years of experience practicing in the community pharmacy setting, including hundreds of biometric screening clinics. Specializing in fingerstick whole blood draws, she's been called a vampire more times than she can count.

Will Anderson, PharmD is the owner and PIC of Orchards Drug in Lawrence, KS. Will passes out when he sees blood, but is a pro at COVID testing, having implemented a high volume COVID testing program at his pharmacy. He focuses on empowering his patients to take control of their health to lead longer, happier lives.

ACCREDITATION INFORMATION
This class is available for pharmacists, pharmacy technicians, and student pharmacists and is ACPE-accredited through the Michigan Pharmacists Association (ACPE Universal Activity #0112-0000-22-200-B04-P/T). Credit is awarded only for completion of the entire 20 contact hour program. Credit must be claimed within 30 days of completing the program.

Questions? Contact Jen Clark at jen@ksrx.org or 785.228.2327.

KPhA appreciates the generous support provided by

Kansas Pharmacists
Association

Preserving, protecting and advancing Kansas pharmacy practice through education, engagement and advocacy.

Contact Us

  • 1020 SW Fairlawn Road
    Topeka, KS 66604
  • 785.228.2327
  • info@ksrx.org
Powered by Wild Apricot Membership Software